DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

H.C. Wainwright Maintains Buy on AcelRx Pharmaceuticals, Lowers Price Target to $7

H.C. Wainwright analyst Ed Arce maintains AcelRx Pharmaceuticals (NASDAQ:ACRX) with a Buy and lowers the price target from $9 to $7.

Benzinga · 03/17/2020 12:36

H.C. Wainwright analyst Ed Arce maintains AcelRx Pharmaceuticals (NASDAQ:ACRX) with a Buy and lowers the price target from $9 to $7.